mesalamine has been researched along with Atherogenesis in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cappello, M | 1 |
Licata, A | 1 |
Calvaruso, V | 1 |
Bravatà, I | 1 |
Aiello, A | 1 |
Torres, D | 1 |
Della Corte, V | 1 |
Tuttolomondo, A | 1 |
Perticone, M | 1 |
Licata, G | 1 |
Craxì, A | 1 |
Cammà, C | 1 |
Rungoe, C | 1 |
Basit, S | 1 |
Ranthe, MF | 1 |
Wohlfahrt, J | 1 |
Langholz, E | 1 |
Jess, T | 1 |
2 other studies available for mesalamine and Atherogenesis
Article | Year |
---|---|
Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Biomarkers; Carotid Arteries; Carot | 2017 |
Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study.
Topics: Adolescent; Adult; Aged; Atherosclerosis; Case-Control Studies; Cohort Studies; Denmark; Female; Fol | 2013 |